TABLE 2.
Variable | Full Sample (N = 871)
|
Treatment as Usual (N = 436)
|
16-Week Matrix (N = 435)
|
|||
---|---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | OR | 95% CI | |
Performance | ||||||
Engagement | 0.93 | 0.63, 1.36 | 0.96 | 0.52, 1.77 | 1.08 | 0.50, 2.33 |
Three Consecutive Negative Urines During Treatment | 2.82*** | 2.04, 3.90 | 3.05** | 1.47, 6.31 | 2.94*** | 2.04, 4.22 |
Proportion of Expected Length of Treatment R Retained | 0.98 | 0.47, 2.06 | 1.22 | 0.44, 3.42 | 0.82 | 0.29, 2.36 |
Demographics | ||||||
Age | 0.97** | 0.94, 0.99 | 0.99 | 0.95, 1.03 | 0.95*** | 0.93, 0.98 |
Female | 0.93 | 0.60, 1.44 | 1.29 | 0.78, 2.13 | 0.73 | 0.40, 1.34 |
White (vs. other) | 0.90 | 0.69, 1.16 | 0.60 | 0.33, 1.09 | 1.14 | 0.79, 1.64 |
Living Arrangement at Baseline (vs. with Partner) | ||||||
No Partner, Alone or with Children | 0.88 | 0.68, 1.14 | 0.95 | 0.67, 1.36 | 0.99 | 0.71, 1.38 |
With Others | 1.01 | 0.74, 1.39 | 1.14 | 0.68, 1.92 | 0.98 | 0.68, 1.42 |
In Controlled Environment | 1.65 | 0.95, 2.86 | 2.45 | 0.58, 10.25 | 1.52 | 0.51, 4.52 |
In an Unstable Situation | 0.43* | 0.22, 0.83 | 0.48 | 0.19, 1.19 | 0.42** | 0.24, 0.73 |
Lived with AOD User at Baseline | 0.69 | 0.45, 1.06 | 0.78 | 0.47, 1.30 | 0.62 | 0.38, 1.01 |
Usual Baseline Employment Status (vs. not Working) | ||||||
Full-time | 1.18 | 0.69, 2.02 | 1.56 | 0.76, 3.22 | 0.82 | 0.40, 1.66 |
Part-time | 1.58 | 0.78, 3.18 | 1.85 | 0.95, 3.63 | 1.17 | 0.33, 4.22 |
Substance Abuse History | ||||||
# AOD Treatments between Baseline and One-Year Follow-up | 1.60*** | 1.27, 2.00 | 1.92** | 1.24, 2.96 | 1.45 | 0.78, 2.70 |
# Days in Past 30 used Meth at Baseline | 0.98 | 0.95, 1.01 | 0.97 | 0.93, 1.01 | 0.98 | 0.95, 1.02 |
Note: SAS PROC GLIMMIX was used for analyses. A random-intercept model was specified, using site as the clustering variable. OR = odds ratio, CI = confidence interval.
p < .05.
p < .01.
p < .001.